TY  - RPRT
TI  - BLIS study: a feasibility randomised controlled trial assessing compliance, acceptability and colonisation with different dosing regimens of the probiotic supplement Streptococcus salivarius K12 (Bactoblis) in adults in England.
AU  - Christopher R Wilcox
AU  - David W Cleary
AU  - Maclyn Augustine
AU  - Rebecca Anderson
AU  - Nick Francis
AU  - Mark Lown
AU  - Michael Moore
AU  - Paul Little
AU  - Stuart C Clarke
AU  - Merlin Willcox
PY  - 2026
DO  - 10.1136/bmjopen-2026-120406
UR  - https://pubmed.ncbi.nlm.nih.gov/42744363/
ID  - 42744363
ER  -